Evidence map›Paper›PMID 23686275›Full record

ArticleMycopathologia2013

The predominance of alternatively activated macrophages following challenge with cell wall peptide-polysaccharide after prior infection with Sporothrix schenckii.

Pamela Alegranci, Livia Carolina de Abreu Ribeiro, Lucas Souza Ferreira, Thais de Cássia Negrini, Danielle Cardoso Geraldo Maia, Aline Tansini, Amanda Costa Gonçalves, Marisa Campos Polesi Placeres, Iracilda Zeppone Carlos

Abstract read
PubMed Publisher
In one paragraph

Article in Mycopathologia, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed
1.4field-weighted citation impact, top 19% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed, 24 citations in OpenAlex.

  1. Current Insights intoJournal of fungi (Basel, Switzerland) · 2025
    Article
  2. Article
  3. Review
  4. Differential Recognition ofInfection and drug resistance · 2023
    Article
  5. Current Models to Study theFrontiers in fungal biology · 2022
    Review
  6. The Role of Macrophages in the Host's Defense againstPathogens (Basel, Switzerland) · 2021
    Review
  7. Murine Macrophage Requires CD11b to RecognizeInfection and drug resistance · 2020
    Article
  8. Sporotrichosis In Immunocompromised Hosts.Journal of fungi (Basel, Switzerland) · 2019
    Review
  9. Immunopathogenesis of Human Sporotrichosis: What We Already Know.Journal of fungi (Basel, Switzerland) · 2018
    Review
  10. Article
  11. Review
  12. Article
  13. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 2 institutions in 1 country.

Pamela AlegranciDepartment of Clinical Analysis, School of Pharmaceutical Sciences, Sao Paulo State University (UNESP), Rua Expedicionários do Brasil no 1621, Araraquara, SP, CEP 14801-902, Brazil.
Livia Carolina de Abreu Ribeiro
Lucas Souza Ferreira
Thais de Cássia Negrini
Danielle Cardoso Geraldo Maia
Aline Tansini
Amanda Costa Gonçalves
Marisa Campos Polesi Placeres
Iracilda Zeppone Carlos
Universidade Estadual Paulista (Unesp) · BRCentro Universitário de Araraquara · BR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Sporotrichosis is a subcutaneous mycosis that is caused by the dimorphic fungus Sporothrix schenckii. This disease generally occurs within the skin and subcutaneous tissues, causing lesions that can spread through adjacent lymphatic vessels and sometimes leading to systemic diseases in immunocompromised patients. Macrophages are crucial for proper immune responses against a variety of pathogens. Furthermore, macrophages can play different roles in response to different microorganisms and forms of activation, and they can be divided into "classic" or "alternatively" activated populations, as also known as M1 and M2 macrophages. M1 cells can lead to tissue injury and contribute to pathogenesis, whereas M2 cells promote angiogenesis, tissue remodeling, and repair. The aim of this study was to investigate the roles of M1 and M2 macrophages in a sporotrichosis model. Toward this end, we performed phenotyping of peritoneal exudate cells and evaluated the concomitant production of several immunomediators, including IL-12, IL-10, TGF-β, nitric oxide, and arginase-I activity, which were stimulated ex vivo with cell wall peptide-polysaccharide. Our results showed the predominance of the M2 macrophage population, indicated by peaks of arginase-I activity as well as IL-10 and TGF-β production during the 6th and 8th weeks after infection. These results were consistent with cellular phenotyping that revealed increases in CD206-positive cells over this period. This is the first report of the participation of M2 macrophages in sporotrichosis infections.

Indexed as

AnimalsAntigens, FungalAscitic FluidCell WallDisease Models, AnimalExudates and TransudatesImmunophenotypingMacrophage ActivationMacrophagesMaleMicePeptidesPolysaccharidesSporothrixSporotrichosisAntigens, FungalPeptidesPolysaccharides

Identifiers

PMID23686275
OpenAlexW1965261799

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.